Welcome to our dedicated page for Ambiq Micro SEC filings (Ticker: AMBQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ambiq Micro, Inc. (NYSE: AMBQ) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a fabless semiconductor company focused on ultra-low-power edge AI solutions, Ambiq uses these filings to report material events, financial results, governance changes, and equity compensation matters related to its SPOT®-based technology business.
Investors can review Form 8-K current reports in which Ambiq furnishes quarterly earnings press releases, detailing net sales, gross profit, operating expenses, net loss, and non-GAAP measures such as non-GAAP gross profit and non-GAAP net loss. These filings also describe business drivers like product mix, geographic revenue shifts, and demand for Apollo and other edge AI platforms. Additional 8-K items document events such as the completion of Ambiq’s initial public offering on the New York Stock Exchange and subsequent board and executive compensation decisions.
Over time, users can expect this page to include annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically provide more detailed discussions of Ambiq’s SPOT technology, Apollo and Atomiq product families, risk factors, and management’s analysis of financial condition and results of operations. These core filings are central for understanding how Ambiq describes its ultra-low-power edge AI strategy and market exposure.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify important changes in revenue trends, operating expenses, or capital structure. The platform also tracks insider-related filings such as Form 4, where available, so users can monitor equity awards and transactions involving Ambiq’s directors and executive officers.
By combining real-time updates from EDGAR with AI-generated insights, this page offers a focused view into AMBQ’s regulatory history, financial reporting practices, and governance developments, all grounded in the company’s official SEC submissions.
Ambiq Micro, Inc. (AMBQ) reported an insider equity award: Sean Chihhsiang Chen, the company's President and COO, received 56,029 restricted stock units (RSUs) on 10/02/2025. Each RSU converts to one share of common stock upon settlement and was granted at a $0 per-share price, indicating a compensatory award rather than a purchase. The RSUs vest 25% on 10/01/2026, with the remaining shares vesting in equal quarterly installments of 1/12 thereafter, subject to continuous service under the 2025 Equity Incentive Plan. The Form 4 discloses 56,029 shares beneficially owned following the grant.
Ambiq Micro director and CEO Fumihide Esaka received a grant of 159,907 restricted stock units (RSUs) on 10/02/2025. Each RSU converts to one share of common stock upon settlement, and following the grant the Reporting Person beneficially owned 176,913 shares. Under the disclosed vesting schedule, 25% of the RSUs vest on 10/01/2026, with the remainder vesting in equal 1/12 portions quarterly thereafter, contingent on continuous service under the company’s 2025 Equity Incentive Plan. The Form 4 was signed by an attorney-in-fact on 10/06/2025.
Ambiq Micro, Inc. reported Board-approved one-time cash bonuses awarded to four senior executives in recognition of their contributions during the company’s initial public offering and to promote retention. The specified cash awards were $328,000 to Fumihide Esaka (Chief Executive Officer), $328,000 to Scott Hanson (Chief Technology Officer), $120,000 to Jeff Winzeler (Chief Financial Officer) and $105,000 to Sean Chen (President and Chief Operating Officer). The filing also discloses that on September 29, 2025 the Board approved acceleration of one-third of Mr. Winzeler’s previously issued stock options, effective October 1, 2025. The disclosure was signed by Jeffery G. Winzeler as Chief Financial Officer.
Ambiq Micro, Inc. (AMBQ) discloses operational and risk details in its quarterly report. The company reported share counts of 347,983,712 shares authorized with 341,496,158 issued and outstanding at June 30, 2025 and December 31, 2024, and separately references a 500,000,000 authorized share figure with smaller issued counts of 450,682 and 434,720 for the same dates. No dividends have been declared and no deemed dividends were recorded for the three and six months ended June 30, 2025. Management (the CEO as CODM) evaluates consolidated revenue, gross margin, operating expenses and net loss for a single operating segment. The filing lists numerous operational risks, including a history of net losses, concentration of end customers, reliance on a single third-party wafer fabricator and limited suppliers, challenges in manufacturing and supply chain, potential IP and regulatory risks, material weakness in internal control over financial reporting, and exposure to geopolitical and macroeconomic events.
Ambiq Micro, Inc. filed a current report to note that it released a press release on September 4, 2025 covering its financial results for the quarter ended June 30, 2025. The company states that this press release is attached as Exhibit 99.1 and is incorporated by reference.
The report clarifies that the earnings information is being "furnished" rather than "filed" under securities laws, which affects how it is treated for certain legal liability purposes and for inclusion in other regulatory documents. The filing is signed on behalf of Ambiq Micro, Inc. by its Chief Financial Officer, Jeffrey G. Winzeler.